About
API Manufacturing
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (10)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
183
By Phase
PHASE1/PHASE2: 1PHASE2: 2PHASE1: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05103345Collaborator
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
PHASE1/PHASE2Recruiting
70 participants
Started: Apr 19, 2023 · Completed: Jun 30, 2028
NCT04182490Collaborator
LMN-101 in a Campylobacter Human Challenge Model
PHASE2Completed
42 participants
Started: Feb 21, 2022 · Completed: Oct 4, 2022
NCT04150250Collaborator
Cholera Anti-Secretory Treatment Trial
PHASE2Completed
47 participants
Started: Nov 4, 2019 · Completed: Jul 27, 2020
NCT04007263Collaborator
A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
PHASE1Completed
24 participants
Started: Apr 4, 2019 · Completed: Oct 10, 2019
Locations (1)
Headquarters
Coventry, RI, United States
Map
Loading map...